Prolonged Zaleplon Treatment Increases the Expression of Proteins Involved in GABAergic and Glutamatergic Signaling in the Rat Hippocampus
Zaleplon is a positive allosteric modulator of the γ-aminobutyric acid (GABA)<sub>A</sub> receptor approved for the short-term treatment of insomnia. Previous publications on zaleplon have not addressed the proteins involved in its mechanism of action but have mostly referred to behavioral or pharma...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2023-12-01
|
| シリーズ: | Brain Sciences |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2076-3425/13/12/1707 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
